Statins increase risk of diabetes in Caucasian men
the ONA take:
According to new research published in the journal Diabetologia, researchers from Finland have found that statin use is associated with an increased risk of developing diabetes.
In the study, researchers analyzed data from 8,749 non-diabetic men in a 6-year follow-up of the population-based Metabolic Syndrome in Men (METSIM) study in Finland.
The participants ranged in age from 45 to 73 years and were followed for 5.9 years. Of those men, 625 were diagnosed with new diabetes during the follow-up period.
Results showed that after adjusting for confounding factors, patients treated with statins were 46% more likely to develop diabetes compared with those non treated with statins. In addition, researchers found that the risk was dose-dependent for atorvastatin and simvastatin.
The authors suggest that the association between statin use and increased risk for diabetes is most likely due to statins decreasing both insulin sensitivity and insulin secretion.
Although the findings are reliable, the study only included Caucasian men and therefore should not be applied to women or people of other ethnic origin without further research.
Statin use is associated with an increased risk of developing diabetes.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|